This Cоurt granted certiorari to review the Court of Appeals’ decision in
Evans v. Rite Aid Corp.,
FactuaivProcedural Background
In October 1989, Myra Kay Evans submitted a drug prescription to Rite Aid Pharmacy (“Pharmacy”). She discovered shortly thereafter that a Pharmacy employee had reported to others that Evans’s medication was for the treatment of a venereal disease. This was not true, as Evans did not have a venereal disease. Evans brought an action against Pharmacy, alleging breach of duty of confidentiality, negligent failure to supervise employees, and outrage. Pursuant to Rule 12(b)(6), SCRCP, Pharmаcy filed a motion to dismiss, which the court granted without prejudice.
Evans filed an amended complaint, alleging negligent falsehood, negligent failure to supervise, and outrage. Pharmacy *272 filed another motion to dismiss. The court granted the motion as to the second arid third causes of action.
Pharmacy moved for summary judgment as to the negligent falsehood claim, which the court construed as defamation and negligent misrepresentation; the court granted the motion. Evans appealed, arguing that the court erred in dismissing her first compláint beсause a professional pharmacist or pharmacy owes to a customer a duty of confidentiality. Moreover, she contended that her second complaint alleged sufficient facts to set forth a cause of action for negligent falsehood. The Court of Appeals found that a pharmacist does not owe a duty of confidentiality to his customer. Further, it determined that the lower court had properly dismissed the negligent falsehood claim. We granted certiorari to review the decision of the Court of Apрeals.
Law/Analysis
A. Pharmacist’s Duty of Confidentiality
Evans argues that a pharmacist or pharmacy owes to a customer purchasing medication a duty of confidentiality, a duty established by statute and the ethical mandate of the profession. We disagree.
She asserts that a duty of confidentiality arises out of S.C.Code Ann. § 40-43-10 et seq. (1986 & Supp.1995), which regulate pharmacists; the public policy set forth in S.C.Code Ann. § 44-29-135 (Supр.1995); and the Code of Ethics of the American Pharmaceutical Association. We do not find that these sources give rise to a duty of confidentiality. The provisions in S.C.Code Ann. § 40-43-10 et seq. regulate the licensing and practice of pharmacists; however, these provisions do not set forth, explicitly or implicitly, a duty of confidentiality.
Second, section 44-29-135 is not of benefit to Evаns. This provision, which is part of the statutory chapter on “Contagious and Infectious Diseases,” states that “[a]ll information and records held by the Department of Health and Environmental Control and its agents relating to a known or suspected case of a sexually transmitted disease are strictly confidential.” It is questionable whether this statute gives rise to a duty of cоnfidentiality on the part of pharmacists, but even if we assume that it does, this would be of no avail to Evans *273 since she, in fact, did not have a sexually transmitted disease. There is no referеnce in these statutes to those who are falsely accused of having a sexually transmitted disease.
Lastly, although the Code of Ethics of the American Pharmaceutical Association may be a potential source of guidance on a pharmacist’s duty of care generally,
see Doe v. American Red Cross Blood Servs.,
It is unnecessary to find a duty of confidentiality when there presently exist other causes of action that address the harm suffered by Evans. The present facts make out a classic сase of defamation: A statement that another is suffering from a loathsome or venereal disease constitutes slander per se. Prosser & Keeton on Torts, § 112 at 790 (1984). Further, Evans could have brought a professional negligence action against the pharmacist under the standards set forth in American Red Cross. Although there is no independent duty of confidentiality, maintaining customer informаtion confidential may well be part of the general standard of care of the professional pharmacist. If so, then Evans could have brought a negligence action in whiсh she could have attempted to prove that Pharmacy deviated from the professional standard of care.
*274 B. Negligent Falsehood
Evans argues that her complaint alleged facts sufficient to make out a cause of action for “negligent falsehood.” We are unaware of any South Carolina case that has recognized such a cause of action. The case cited by Evans in support of her argument,
South Carolina State Ports Authority v. Booz-Allen & Hamilton, Inc.,
In South Carolina, one may bring an action sounding in tort for negligent misrepresentation. ‘A duty to exercise reasоnable care in giving information exists when the defendant has a pecuniary interest in the transaction.’ ‘The recovery of damages may be predicated upon a negligently made false statement where a party suffers either injury or loss as a consequence of relying upon the misrepresentation.’ These general rules have been appliеd ... to support the recognition of a negligent misrepresentation claim where the misrepresented fact(s) induced the plaintiff to enter a contract or business transaсtion.
Gilliland v. Elmwood Properties,
In rejecting Evans’s claim for negligent falsehood, the Court of Appeals partly interpreted the action as one in negligence. It reasoned that Evans cannot assert a negligence claim beсause Pharmacy owed no duty to her. Evans’s complaint cannot be construed as alleging a cause of action for negligence; therefore, this issue should not have beеn reached. Moreover, the analysis of the Court of Appeals may be misconstrued as suggesting that pharmacies owe no duty of care to customers.
See contra French Drug Co. v. Jones,
In South Carolina,
American Red Cross,
Conclusion
Based on the foregoing, the decision of the Court of Appeals is AFFIRMED AS MODIFIED.
Notes
. Our research reveals only two cases tangentially related to the issue before us. In
Griffin v. Phar-Mor, Inc.,
In
Suarez v. Pierard,
